Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 3
1984 3
1985 2
1986 5
1987 1
1988 1
1989 2
1990 3
1991 1
1992 2
1993 5
1994 2
1995 3
1997 2
2000 2
2003 2
2004 2
2005 1
2006 4
2007 3
2008 2
2009 2
2010 1
2011 1
2012 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Hemodialysis hypereosinophilia.
Cledes J, Guillodo MP, Hervé JP, Bourbigot B, Gentric A, Treguer MH, Wehbe B, Le Bihan G. Cledes J, et al. Among authors: bourbigot b. Contrib Nephrol. 1988;62:109-17. doi: 10.1159/000415481. Contrib Nephrol. 1988. PMID: 3258804 No abstract available.
Oral water intoxication in babies.
Tanneau RS, Bourbigot B. Tanneau RS, et al. Among authors: bourbigot b. Lancet. 1992 May 16;339(8803):1229. doi: 10.1016/0140-6736(92)91165-5. Lancet. 1992. PMID: 1349957 No abstract available.
Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab.
Krämer BK, Neumayer HH, Stahl R, Pietrzyk M, Krüger B, Pfalzer B, Bourbigot B, Campbell S, Whelchel J, Eris J, Vitko S, Budde K; RADA2307 Study Group. Krämer BK, et al. Among authors: bourbigot b. Transplant Proc. 2005 Apr;37(3):1601-4. doi: 10.1016/j.transproceed.2004.09.026. Transplant Proc. 2005. PMID: 15866684 Clinical Trial.
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients.
Tedesco-Silva H Jr, Vitko S, Pascual J, Eris J, Magee JC, Whelchel J, Civati G, Campbell S, Alves-Filho G, Bourbigot B, Garcia VD, Leone J, Esmeraldo R, Rigotti P, Cambi V, Haas T; 2306 and 2307 study groups. Tedesco-Silva H Jr, et al. Among authors: bourbigot b. Transpl Int. 2007 Jan;20(1):27-36. doi: 10.1111/j.1432-2277.2006.00414.x. Transpl Int. 2007. PMID: 17181650 Free article. Clinical Trial.
Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies.
Vitko S, Tedesco H, Eris J, Pascual J, Whelchel J, Magee JC, Campbell S, Civati G, Bourbigot B, Alves Filho G, Leone J, Garcia VD, Rigotti P, Esmeraldo R, Cambi V, Haas T, Jappe A, Bernhardt P, Geissler J, Cretin N. Vitko S, et al. Among authors: bourbigot b. Am J Transplant. 2004 Apr;4(4):626-35. doi: 10.1111/j.1600-6143.2004.00389.x. Am J Transplant. 2004. PMID: 15023156 Free article. Clinical Trial.
Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group.
Lebranchu Y, Aubert P, Bayle F, Bedrossian J, Berthoux F, Bourbigot B, Buchler M, Chalopin JM, Deteix P, Glotz D, Huraut De Ligny B, Kessler M, Lang P, Lefrancois N, Le Pogamp P, Moulin B, Mourad G, Olmer M, Sraer JD, Touchard G, Toupance O, Wolf P, Puget S. Lebranchu Y, et al. Among authors: bourbigot b. Transplant Proc. 2000 Mar;32(2):396-7. doi: 10.1016/s0041-1345(99)00992-6. Transplant Proc. 2000. PMID: 10715452 Clinical Trial. No abstract available.
57 results